GWAS meta-analysis identifies 10 CSC loci and links genetic risk to OCT abnormalities
Genetic clues point to new pathways for Central Serous Chorioretinopathy
This meta-analysis of GWAS data from European-ancestry cohorts identified 10 genome-wide significant loci for central serous chorioretinopat…
A massive genetic study finds specific DNA spots linked to Central Serous Chorioretinopathy, offering new targets for future treatment resea…
Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman
Rare heart attack possible after fluorescein angiography in older adults with heart disease
This case report and review of the literature describes a 76-year-old woman with hypertension, hyperlipidemia, and type 2 diabetes mellitus …
A 76-year-old woman with heart disease had a heart attack shortly after a dye test, highlighting rare risks.
Narrative review outlines risk stratification and selective intervention for peripheral retinal degenerations
New imaging helps doctors decide when to treat risky eye spots before tears form
This narrative review synthesizes evidence from 29 studies regarding the management of peripheral retinal degenerations. The authors propose…
A review of 29 studies shows how better imaging and AI can help doctors decide when to treat risky eye spots before tears form.
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues
New data shows netarsudil offers a safer option for some glaucoma patients
A Bayesian network meta-analysis found netarsudil ranked lower for IOP reduction but had a more favorable conjunctival hyperemia profile com…
A fresh look at glaucoma drugs shows one option causes less redness while still helping lower eye pressure effectively.
Narrative review of injectable corneal endothelial cell therapy for Fuchs endothelial corneal dystrophy and pseudophakic bullous keratopathy
Millions With Cloudy Vision May Skip Corneal Transplant Surgery Soon
This narrative review examines pre-clinical and clinical data on injectable corneal endothelial cell (CEC) therapy for Fuchs endothelial cor…
• A simple eye injection restores clear vision without surgery • Helps people with Fuchs dystrophy or post-cataract swelling • Still in tria…
FDA Approves Pavblu (aflibercept) for Neovascular AMD, RVO, DME, and DR
FDA approves Pavblu to treat several eye conditions that cause vision loss.
The FDA approved Pavblu (aflibercept) for neovascular AMD, macular edema following RVO, DME, and DR. It is a VEGF inhibitor administered by …
The FDA approved Pavblu (aflibercept) for wet age-related macular degeneration, macular edema, diabetic macular edema, and diabetic retinopa…
Systematic review of extensive macular atrophy with pseudodrusen reports visual acuity decline and atrophy progression
Eye disease linked to vision loss and thicker eye layers in study
This systematic review and meta-analysis of 1096 eyes with extensive macular atrophy with pseudodrusen (EMAP) found a mean visual acuity dec…
A review of over 1,000 eyes shows EMAP leads to significant vision loss and thicker eye layers over time.
Obstructive Sleep Apnea Associated with Higher Odds of Age-Related Macular Degeneration
Large study links obstructive sleep apnea to higher risk of age-related macular degeneration
A systematic review and meta-analysis of 3,536,314 adults found that obstructive sleep apnea (OSA) was associated with higher odds of age-re…
A massive analysis of over 3.5 million people suggests obstructive sleep apnea is linked to a higher risk of age-related macular degeneratio…
Systematic review and meta-analysis shows aflibercept biosimilars match reference drug efficacy and safety in AMD and DME
Aflibercept biosimilars match the original drug for eye disease treatment
This systematic review and meta-analysis evaluated aflibercept biosimilars versus reference aflibercept for neovascular age-related macular …
A large review of 4064 patients found that aflibercept biosimilars work just as well as the original drug for two common eye conditions.
Meta-analysis of tafluprost-timolol fixed-dose combination for open-angle glaucoma and ocular hypertension
Tafluprost-timolol drops lower eye pressure than switching to single drugs
This meta-analysis evaluated the tafluprost-timolol fixed-dose combination versus a monotherapy switch group in patients with open-angle gla…
A meta-analysis of 2066 patients found that fixed-dose tafluprost-timolol lowered eye pressure more than switching to monotherapy, with mini…
Mingmu Dihuang Tang plus conventional treatment improved visual acuity and reduced complications in elderly cataract patients
Trial shows Mingmu Dihuang Tang plus Western medicine improves cataract markers
This randomized controlled trial enrolled 120 elderly patients with cataract.
Adding Mingmu Dihuang Tang to standard care improved antioxidant levels and vision recovery in elderly patients with cataracts.
AI-based fluid volume quantification predicts visual acuity in neovascular AMD better than CST
AI fluid measurements better predict vision loss than thickness in AMD
This randomized phase III trial in 290 eyes with neovascular AMD found that AI-based quantification of intraretinal and subretinal fluid vol…
AI-based fluid volume tracking explains more vision changes than standard thickness measurements in macular degeneration patients.